Human variability in hepatic and renal elimination: implications for risk assessment

scientific article published on September 2007

Human variability in hepatic and renal elimination: implications for risk assessment is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/JAT.1255
P698PubMed publication ID17497760
P5875ResearchGate publication ID6333840

P2093author name stringDorne JL
P2860cites workBiotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adultsQ34346647
Factors affecting the absolute bioavailability of nifedipineQ34347120
Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicantsQ35827686
Data-derived safety factors for the evaluation of food additives and environmental contaminantsQ36767849
Safety factors and establishment of acceptable daily intakesQ37238541
The concept of the acceptable daily intake: an historical reviewQ37238544
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)411-420
P577publication date2007-09-01
P1433published inJournal of Applied ToxicologyQ3186896
P1476titleHuman variability in hepatic and renal elimination: implications for risk assessment
P478volume27

Reverse relations

cites work (P2860)
Q58680978An update on metabolism studies using human hepatocytes in primary culture
Q53573948Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Q37172950Background, approaches and recent trends for setting health-based occupational exposure limits: a minireview
Q38137867Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants
Q104754396ESTIMATION OF TOLUENE EXPOSURE IN AIR FROM BMA (S-BENZYLMERCAPTURIC ACID) URINARY MEASURES USING A REVERSE DOSIMETRY APPROACH BASED ON PHYSIOLOGICALLY PHARMACOKINETIC MODELING
Q38586048Ethnic differences in adverse drug reactions to asthma medications: a systematic review
Q38691542Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance
Q89680369High-throughput screening tools facilitate calculation of a combined exposure-bioactivity index for chemicals with endocrine activity
Q36324193Induction of the Estrogenic Marker Calbindn-D₉k by Octamethylcyclotetrasiloxane
Q35864881Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach
Q38193579Sources of variability in biomarker concentrations
Q47145601Toxicokinetics of Bisphenol A ‐ Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC)

Search more.